Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine: A New Therapeutic Perspective in Cardiovascular Disease

Author： Dario DiFrancesco  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.16, 2004-01, pp. : 1757-1765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heart Rate-Lowering Efficacy and Respiratory Safety of Ivabradine in Patients with Obstructive Airway Disease: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

By Majewski Sebastian  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 179-188

Adis International

Access to resources Recommend Favorite

Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease

By Sunder-Plassmann G.   Winkelmayer W.C.   Födinger M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2637-2652

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis in Cardiovascular Disease: Current Status and Therapeutic Potential

By Sellke F.W.   Simons M.  

Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. : 391-396

Adis International

Access to resources Recommend Favorite

Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease

By  

Current Medicinal Chemistry, Vol. 20, Iss. 14, 2013-05 ,pp. : 1817-1823

Bentham Science Publishers

Access to resources Recommend Favorite

Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1193-1209

Bentham Science Publishers

Access to resources Recommend Favorite